Skip to main content
Professionals

Please explore the resources below:

Audience




Type
















Conditions


































Procedures












Other










Back to Categories

Results in 'Consensus Statements and Guidelines' and 'Pathology'

BSG-ACPGBI guidelines for the management of large non-pedunculated colorectal polyps

17 August 2021
Consensus Statements and Guidelines

These guidelines provide an evidence-based framework for the management of patients with large nonpedunculated colorectal polyps.

Public Health England NHS Bowel Screening Programme: Guidance on reporting lesions

3 August 2021
Consensus Statements and Guidelines

This document supports consistent practice in pathology in the NHS Bowel Cancer Screening Programme (BCSP), as well as developing the evidence base for future recommendations regarding routine practice.

BSG guidelines on inflammatory bowel disease biopsies

3 August 2021
Consensus Statements and Guidelines

The British Society of Gastroenterology

3 August 2021
Consensus Statements and Guidelines

The Royal College of Pathologists

3 August 2021
Consensus Statements and Guidelines
Presentations, Videos & Papers

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2 August 2021
Consensus Statements and Guidelines

A comprehensive guideline produced by the European Society of Medical Oncology in 2017.

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2 August 2021
Consensus Statements and Guidelines

A comprehensive guideline produced by the European Society of Medical Oncology in 2014.

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2 August 2021
Consensus Statements and Guidelines

Incidence and epidemiology Colorectal cancer (CRC) is the third most common tumour in men and the second in women, accounting for 10% of all tumour types worldwide. Incidence is 25% higher in males and differs greatly between countries. With more than 600 000 deaths estimated each year, CRC is the fourth most common cancer-related cause of death globally.1,2 The growing incidence in some countries reflects a modification in lifestyle and its consequences related with ‘Westernisation’ such as obesity, physical inactivity, alcohol consumption, high red meat intake and cigarette smoking.3 Some data suggest a putative role in colon cancer carcinogenesis for factors that cause imbalances in gut microbiota

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2 August 2021
Consensus Statements and Guidelines

INCIDENCE AND EPIDEMIOLOGY Anal cancer is a rare disease that accounts for <1% and <3% of all new cancer diagnoses and gastrointestinal tumours, respectively. The most common histological subtype is squamous-cell carcinoma of the anus (SCCA) with an annual incidence of 0.5-2.0 in 100 000.1